Download full report with analyst certification and important disclosures
Nov 6 2024, 07:28 GMT
Glanbia
Q3 update: guidance reiterated; transformation programme announced
DAVY VIEW
Glanbia has reiterated its full year guidance of 5-8% EPS growth, as such we envisage no material change to our FY24 forecasts. The group has announced the separation of its Glanbia Nutritionals (GN) business into two new segments — Health & Nutrition and Dairy Nutrition. Congruently, Glanbia is commencing a transformation programme to enable growth with enhanced productivity across the group. A new €50m buyback was announced, which will commence in 2025. Management will host a conference call at 08:30.
